QR-Code

COVID-19 outcomes in patients with a history of immune-mediated glomerular diseases

IntroductionPatients with immune-mediated glomerular diseases are considered at high risk for severe COVID-19 outcomes. However, conclusive evidence for this patient population is scarce.MethodsWe created a global registry and retrospectively collected clinical data of patients with COVID-19 and a p...

Ausführliche Beschreibung

Gespeichert in:
Hauptverfasser: Philipp Gauckler, Jana S. Kesenheimer, Duvuru Geetha, Balazs Odler, Kathrin Eller, Timothee Laboux, Federico Alberici, Mattia Zappa, Natasha Chebotareva, Sergey Moiseev, Marco Bonilla, Kenar D. Jhaveri, Julie Oniszczuk, Vincent Audard, Denise Costa, Gianna Mastroianni-Kirsztajn, Annette Bruchfeld, Masahiro Muto, Martin Windpessl, Gert Mayer, Andreas Kronbichler
Format: Artigo
Sprache:Inglês
Veröffentlicht: Frontiers Media S.A. 2023-09-01
Schriftenreihe:Frontiers in Immunology
Schlagworte:
coronavirus
risk factor
autoimmune disease
kidney disease
glomerulonephritis
immunosuppression
Online-Zugang:https://www.frontiersin.org/articles/10.3389/fimmu.2023.1228457/full
Tags: Tag hinzufügen
Keine Tags, Fügen Sie das erste Tag hinzu!

Ähnliche Einträge